Shineco Raises $13.5 Million in Stock Sale to Non-U.S. Investors

Shineco, Inc. has raised $13.5 million through a stock sale by selling 18 million shares at $0.75 per share to non-U.S. investors. The transaction closed on July 2, 2025, resulting in gross proceeds for the company before expenses. Shineco is a biotech company focused on developing natural and biological products.

Shineco, Inc., a biotech company specializing in the development of natural and biological products, has successfully raised $13.5 million through a stock sale. The company sold 18 million shares at $0.75 per share to non-U.S. investors, closing the transaction on July 2, 2025. This funding round comes as Shineco aims to bolster its research and development efforts in the biotech sector [1].

The stock sale follows a significant drop in Shineco's stock price over the past month, with shares falling around 64% and reaching a 52-week low of $0.15. Despite the recent decline, Shineco's stock price showed a positive trend on Tuesday, gaining 6.9% to close at $0.17. The Relative Strength Index (RSI) for Shineco's stock is currently at 28, indicating that the stock is considered oversold and may present an opportunity for investors [1].

Shineco's stock performance aligns with the broader trends in the consumer staples sector, where several major players have seen their stocks fall to oversold levels. This situation presents an opportunity for investors to buy into undervalued companies in the sector [1].

As Shineco continues to focus on its research and development, the company's ability to capitalize on this funding will be crucial for its long-term growth and success in the competitive biotech market.

References:
[1] https://www.benzinga.com/trading-ideas/long-ideas/25/07/46316741/top-3-risk-off-stocks-that-may-rocket-higher-in-q3